TB Research
← Back to search

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Kernel Networks Inc.

Case Medical Research · 2019-08

Abstract

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care - Full Text View.

MeSH terms

  • Bedaquiline
  • Linezolid
  • Medicine
  • Rifampicin
  • Short course
  • Tuberculosis
  • Standard of care
  • Intensive care medicine
  • Internal medicine